Grid view List view

Phenoxodiol

Phenoxodiol is a Pan-cancer drug; causes apoptosis via both intrinsic and extrinsic pathways; targets plasma membrane electron transport (PMET).

Dehydroequol produces vasodilatation in human resistance arteries via a nitric oxide-dependent mechanism.

CoA A160

MSDS A160

TFMISO

potential for selective chemotherapy and diagnosis of hypoxic cells

A-803467

Selective blocker of NaV1.8 channels (IC50 values are 8, 2450, 6740, 7340 and 7380 nM for hNaV1.8, hNaV1.3, hNaV1.7, hNaV1.5 and hNaV1.2 channels respectively). Shows no significant activity against T

RPV1, P2X2/3, CaV2.2 and KCNQ2/3 channels. Antinociceptive; potently attenuates mechanical allodynia in two models of neuropathic pain following i.p. administration.

MSDS UN168

CoA UN168

Amonafide

Topoisomerase II inhibitor

used in the treatment of cancer. It belongs to the families of drugs called topoisomerase inhibitors and DNA intercalators.

MSDS FD013

CoA FD013